The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...

Unsurprisingly, CVS Health, Cigna, and UnitedHealth Group stocks fell last week after the FTC lawsuit announcement. But are ...

In a landmark move, the FTC filed a lawsuit targeting the “Big Three” PBMs: CVS Health’s Caremark Rx, Cigna’s Express Scripts (ESI), and UnitedHealth Group’s OptumRx. The suit also includes their ...

When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...

FTC files lawsuit against top PBMs and GPOs for alleged anticompetitive practices in inflating insulin prices. Learn about the allegations and responses.

Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for ...

The Senate HELP Committee held a hearing to address the high cost of semaglutide drugs, finding that many patients cannot ...

Novo Nordisk's CEO faced lawmakers in a grueling 2.5-hour hearing to discuss the cost of blockbuster drugs Ozempic and Wegovy ...

What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.